Cameco Reports Document Filings
Cameco (TSX: CCO; NYSE: CCJ) reported today that it filed a technical report for the Inkai operation on a voluntary basis under National Instrument 43-101 – Standards of Disclosure of Mineral Projects (“NI 43-101”). The technical report is being filed to provide updated information relating to the Inkai operation and not as a result of a requirement under NI 43-101. The technical report has been posted on our website and SEDAR+ at www.sedarplus.ca and on EDGAR on the SEC website at www.sec.gov. Our website, SEDAR+ and EDGAR are not part of this press release and are not incorporated by reference herein. Readers are encouraged to read the technical report in its entirety, including all qualifications, assumptions and exclusions therein.
Cameco Marks Uranium Supply Agreement with China Nuclear International Corporation
Cameco (TSX: CCO; NYSE: CCJ) has signed a uranium supply agreement with China Nuclear International Corporation, a subsidiary of China National Nuclear Corporation (CNNC), one of the country’s largest nuclear power operators.
Cameco Reports First Quarter Results, Solid Quarter Demonstrating the Strength and Purpose of Our Strategy; Long-Term Contracting Success in New Markets; Still Early Days of a Market Transition
Cameco (TSX: CCO; NYSE: CCJ) today reported its consolidated financial and operating results for the first quarter ended March 31, 2023, in accordance with International Financial Reporting Standards (IFRS).
Cameco announces US$650 million bought deal offering of common sharesSASKATOON, Saskatchewan, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Cameco (TSX: CCO; NYSE: CCJ) today announced that it has entered into an agreement with a syndicate of underwriters led by CIBC Capital Markets and Goldman Sachs & Co. LLC, pursuant to which the underwriters have agreed to purchase, on a bought deal basis, 29,615,000 common shares of Cameco at a price of $21.95 per share (the “Offering Price”), for gross proceeds to us of approximately $650 million (the “Offering”). The common shares will be offered to the public in Canada and the United States. The Offering is expected to close on or about October 17, 2022, subject to customary closing conditions, including receipt of all necessary approvals of the Toronto Stock Exchange and the New York Stock Exchange. Additionally, we have granted the underwriters an option to purchase up to an additional 4,442,250 common shares at the Offering Price, exercisable in whole or in part at any time up to 30 days following the closing of the Offering, for potential additional gross proceeds to Cameco of approximately $97.5 million.
Cameco provides preliminary third quarter operating updateSASKATOON, Saskatchewan, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Cameco (TSX: CCO; NYSE: CCJ) today is providing preliminary operating results for its third quarter ended September 30, 2022.
Cameco Announces Second Quarter Results, Continued Disciplined Execution of Strategy; Well-Positioned as Multi-Asset Nuclear Fuel Supplier Across the Fuel Cycle
Cameco (TSX: CCO; NYSE: CCJ) today reported its consolidated financial and operating results for the second quarter ended June 30, 2022 in accordance with International Financial Reporting Standards (IFRS).
